The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...

The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.

MIT researchers created a nanosensor catheter that detects bladder cancer biomarkers far earlier than current tests.

Bladder Cancer Edition Part 2 / advanced urothelial carcinoma, Andrea Necchi, Antibody drug conjugates, Astellas, bladder ...

On October 25, 2026, OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition brought together leading oncology experts ...

Perioperative treatment with durvalumab (Imfinzi) plus neoadjuvant enfortumab vedotin (EV) significantly improved event-free survival (EFS) and overall survival (OS) compared with radical cystectomy ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...

A new review explains why BCG immunotherapy fails in some bladder cancer patients and outlines emerging combination ...

The decision gives certain patients whose cancer has resisted BCG therapy another treatment option aimed at preserving the ...

A retrospective cohort of 60 patients found that bladder preservation was feasible after a complete response to neoadjuvant ...

Learn about types of incontinence pads for MS, differences between bladder and menstrual pads, skin protection tips, insurance coverage, and when to seek medical help.

Georgia Lee Hampshire, 27, was taking up to 14g of a drug every day at the height of her 10-year addiction, suffering ...